Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Metabolism of 2-deoxy-2-[18F]fluoro-D-glucose: presence of 2-deoxy-2-[18F]fluoro-D-glucose 6-phosphate in plasma of mice, rats, and humans.

× No keyword cloud information.

9 in total

1. Metabolic trapping as a principle of oradiopharmaceutical design: some factors resposible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose.

Authors: B M Gallagher; J S Fowler; N I Gutterson; R R MacGregor; C N Wan; A P Wolf
Journal: J Nucl Med Date: 1978-10 Impact factor: 10.057

2. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

Authors: L Sokoloff; M Reivich; C Kennedy; M H Des Rosiers; C S Patlak; K D Pettigrew; O Sakurada; M Shinohara
Journal: J Neurochem Date: 1977-05 Impact factor: 5.372

3. The [18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man.

Authors: M Reivich; D Kuhl; A Wolf; J Greenberg; M Phelps; T Ido; V Casella; J Fowler; E Hoffman; A Alavi; P Som; L Sokoloff
Journal: Circ Res Date: 1979-01 Impact factor: 17.367

4. Uridylate trapping induced by the C-2-modified D-glucose analogs glucosone, fluoroglucose, and glucosamine.

Authors: A Holstege; C Schulz-Holstege; H Henninger; K A Reiffen; F Schneider; D O Keppler
Journal: Eur J Biochem Date: 1982-01

5. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method.

Authors: M E Phelps; S C Huang; E J Hoffman; C Selin; L Sokoloff; D E Kuhl
Journal: Ann Neurol Date: 1979-11 Impact factor: 10.422

9. Studies on 18F-labeled pyrimidines III. Biochemical investigation of 18F-labeled pyrimidines and comparison with 3H-deoxythymidine in tumor-bearing rats and mice.

Authors: K Ishiwata; T Ido; Y Abe; T Matsuzawa; M Murakami
Journal: Eur J Nucl Med Date: 1985

9 in total

Metabolism of 2-deoxy-2-[18F]fluoro-D-glucose: presence of 2-deoxy-2-[18F]fluoro-D-glucose 6-phosphate in plasma of mice, rats, and humans.

1. Metabolic trapping as a principle of oradiopharmaceutical design: some factors resposible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose.

2. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

3. The [18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man.

4. Uridylate trapping induced by the C-2-modified D-glucose analogs glucosone, fluoroglucose, and glucosamine.

5. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method.

6. Metabolism of 2-deoxy-2-fluoro-D-[3H]glucose and 2-deoxy-2-fluoro-D-[3H]mannose in yeast and chick-embryo cells.

7. The deoxyfluoro-D-glucopyranose 6-phosphates and their effect on yeast glucose phosphate isomerase.

8. Metabolism of 2-[18F]fluoro-2-deoxyglucose in tumor-bearing rats: chromatographic and enzymatic studies.

9. Studies on 18F-labeled pyrimidines III. Biochemical investigation of 18F-labeled pyrimidines and comparison with 3H-deoxythymidine in tumor-bearing rats and mice.